MAYNE PHARMA
Live / Registered — Registered (as of 01 Jul 2025)
What this means for you
Registered since 01 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98376011
- Registration number
- 7853273
- Mark type
- Design + words
- Filed
- 25 Jan 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 01 Jul 2025
- Attorney of record
- Melissa A. Nowak
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the field of gynecology and women's health, namely, contraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins
- Class 010 — Medical apparatus: contraceptive apparatus in the field of gynecology and women's health
Owner
- Mayne Pharma International Pty Ltd, SALISBURY SOUTH SA, AU
- Mayne Pharma International Pty Ltd, SALISBURY SOUTH SA, AU
- Mayne Pharma International Pty Ltd, SALISBURY SOUTH SA, AU
Prior registrations
Prosecution history
- 01 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Feb 2025 — USE AMENDMENT FILED
- 15 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jan 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 21 Jan 2025 — ASSIGNED TO PETITION STAFF
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Dec 2024 — TEAS POST PUBLICATION AMENDMENT RECEIVED